UAE
Bahrain
Jordan
Kuwait
Oman
Qatar
Saudi ArabiaHealth News
Identification Of Female Gene Link Offers New Hope For Migraine Sufferers
Date: Jun-05-2012New hope has arrived for migraine sufferers following a Griffith University study with the people of Norfolk Island. Led by Professor Lyn Griffiths from the University's Griffith Health Institute, the team has identified a new region on the X chromosome as playing a role in migraine. The research provides compelling evidence for a new migraine susceptibility gene involved in migraine. The study also indicated that there may be more than one X chromosomal gene involved and implicated a gene involved in iron regulation in the brain...
Disparities In Cancer Care Associated With A Patient's Socioeconomic Status
Date: Jun-05-2012Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival - cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic - such as age or disease site - is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment. Yu-Ning Wong, M.D...
New Therapy On The Horizon For ALK+ Non-Small Cell Lung Cancer
Date: Jun-05-2012A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to crizotinib - the only approved ALK inhibitor. Results of this Novartis-sponsored sudy were presented by a researcher from Fox Chase Cancer Center during the 2012 Annual Meeting of the American Society of Clinical Oncology...
Not All Patients Will Pay For Genetic Testing
Date: Jun-05-2012More than one-fifth of people who have received referrals to test for cancer-causing genes say they will only undergo testing if their insurance covers the cost - just as more insurers are instituting cost-sharing for medical services like genetic testing, according to new findings from Fox Chase Cancer Center in Philadelphia released at this year's 2012 Annual Meeting of the American Society of Clinical Oncology...
New Insights Into The Health Implications Of Different Types Of Trans Fat
Date: Jun-05-2012The latest research builds on ground-breaking new knowledge on a special 'family' of natural trans fats that are produced by ruminant animals such as dairy and beef cattle, goats and sheep, and found in the milk and meat from these animals. The findings strengthen the evidence that, unlike industrial trans fats, these natural ruminant trans fats are not harmful and may in fact have health-enhancing potential. The key findings were presented at the 10th Congress for the International Society for the Study of Fatty Acids & Lipids (ISSFAL)...
Cancer Patients On Lower Incomes Less Likely To Be Involved In Clinical Trials
Date: Jun-05-2012Cancer patients with annual household incomes below $50,000 were less likely to participate in clinical trials than patients with annual incomes of $50,000 or higher, and were more likely to be concerned about how to pay for clinical trial participation. This is the conclusion of a large study by the SWOG cancer research cooperative group that was presented at the annual meeting of the American Society for Clinical Oncology (ASCO) in Chicago this week...
Prostate Cancer Patients Fare Better On Continuous Hormone Therapy When Compared With Intermittent Hormone Therapy
Date: Jun-05-2012Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, a cancer research cooperative group funded by the National Cancer Institute (NCI). Men with newly diagnosed metastatic prostate cancer are usually either surgically castrated or given medications to suppress the production of male hormones that drive their cancer...
New Research Shows Foggers Are Ineffective Against Bed Bugs
Date: Jun-05-2012Consumer products known as "bug bombs" or "foggers" have been sold for decades for use against many common household insects. However, recent research published in the Journal of Economic Entomology (JEE) shows these products to be ineffective against bed bugs. In "Ineffectiveness of Over-the-Counter Total-Release Foggers Against the Bed Bug (Heteroptera: Cimicidae)," an article appearing in the June issue of JEE, authors Susan C. Jones and Joshua L...
Differences In Breast Cancer May Be Indicated By A Newly Discovered DNA Marker
Date: Jun-05-2012Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered a potential explanation for why breast cancer is not experienced the same way with African American and Caucasian patients. This data was presented at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting. Breast cancer is more common in Caucasian women than in African American women; however, African American women experience a more aggressive form of breast cancer that occurs almost a decade earlier than Caucasian women...
Off-Label Antibiotic Use In Agriculture Should Be Banned In Canada
Date: Jun-05-2012Canada should ban off-label use of antibiotics in farm animals because it contributes significantly to antibiotic resistance in humans, states an editorial in CMAJ (Canadian Medical Association Journal). Off-label use means using antibiotics for purposes other than those indicated on the label. "Of greatest concern is the promotion of resistance to antibiotics that may currently represent the last resort for treating some highly resistant infections in humans," writes Barbara Sibbald, Deputy Editor, CMAJ...
Stay Connected
